Drug targeting inflammation helps improve the effects of stroke

Share this article:

A new delivery method for a drug delivered to the central nervous system holds hope for treating brain inflammation that comes after a stroke, researchers have found. The effect can be realized years after a stroke, they said.

The drug, etanercept, has been successful in treating other inflammatory diseases, such as rheumatoid arthritis. The drug works by neutralizing tumor necrosis factor, a cytokine that initiates and amplifies inflammation.

When etanercept was administered to three stroke patients, all demonstrated improvement in areas such as motor function, gait, hand function, sensory deficits, spatial perception, speech and cognition within 10 minutes. The results of the study were published in Tuesday's issue of CNS Drugs.
Share this article:

More in News

Dignity Award Gold won by Archie Hendricks Sr. SNF

Dignity Award Gold won by Archie Hendricks Sr. ...

A skilled nursing facility that sits on a Native American reservation has taken Gold in the Dignity category for the third annual McKnight's Excellence in Technology Awards.

Therapeutic program reverses Alzheimer's memory loss, UCLA researcher says

An intensive therapy regimen involving medication, diet and behavioral changes successfully reversed Alzheimer's-related memory loss in a first-of-its-kind trial, according to findings out of the University of California, Los Angeles.

Employee cleared of sexual assault charges wins $1 million defamation suit against ...

A former assisted living worker in South Carolina has received a $1 million award after being falsely accused of trying to sexually assault a resident, according to local news sources.